Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinematic-guided Xeomin for Hand Tremor in ET and PD
NCT02427646Phase 2Unknown
- Sponsor
- Western University
- Start
- Oct 2011
- Primary completion
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of botulinum toxin type A in essential tremor (ET), Parkinson's disease (PD), sponsored by Western University. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
essential tremor (ET)Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02427646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427646.